News | July 21, 2025
Aarti Drugs posts Q1 FY26 PAT higher at Rs. 54 Cr
During Q1FY26, the company incurred Capex of ~Rs. 48.5 crores mainly towards capacity expansion, backward integration and finished formulation R&D
During Q1FY26, the company incurred Capex of ~Rs. 48.5 crores mainly towards capacity expansion, backward integration and finished formulation R&D
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
To streamline complex medical writing workflows with GenAI
Friesland Campina Professional’s innovative Kievit portfolio features fat powders, creamers, foamers, whipping agents, cake emulsifiers
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
The site, spanning approximately 25,000 square meters, is expected to commence operations by the end of 2025
The pet dog population alone is expected to increase from 21.4 million in 2019 to 51.5 million by 2028
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
The inspection concluded successfully, with the facility found to be in compliance with the required regulations
Zydus receives EIR for the API manufacturing facility at Ankleshwar
Subscribe To Our Newsletter & Stay Updated
